217 related articles for article (PubMed ID: 18983664)
41. Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1.
Guo L; Song N; He T; Qi F; Zheng S; Xu XG; Fu Y; Chen HD; Luo Y
Mol Carcinog; 2015 Nov; 54(11):1340-53. PubMed ID: 25175281
[TBL] [Abstract][Full Text] [Related]
42. Purification and characterization of recombinant murine endostatin in E. coli.
You WK; So SH; Lee H; Park SY; Yoon MR; Chang SI; Kim HK; Joe YA; Hong YK; Chung SI
Exp Mol Med; 1999 Dec; 31(4):197-202. PubMed ID: 10630374
[TBL] [Abstract][Full Text] [Related]
43. Endostatin specifically targets both tumor blood vessels and lymphatic vessels.
Zhuo W; Chen Y; Song X; Luo Y
Front Med; 2011 Dec; 5(4):336-40. PubMed ID: 22198745
[TBL] [Abstract][Full Text] [Related]
44. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
Du Z; Hou S
J Urol; 2003 Nov; 170(5):2000-3. PubMed ID: 14532841
[TBL] [Abstract][Full Text] [Related]
45. Endostatin action and intracellular signaling: beta-catenin as a potential target?
Dixelius J; Cross MJ; Matsumoto T; Claesson-Welsh L
Cancer Lett; 2003 Jun; 196(1):1-12. PubMed ID: 12860282
[TBL] [Abstract][Full Text] [Related]
46. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.
Becker CM; Sampson DA; Short SM; Javaherian K; Folkman J; D'Amato RJ
Fertil Steril; 2006 Jan; 85(1):71-7. PubMed ID: 16412733
[TBL] [Abstract][Full Text] [Related]
47. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
[TBL] [Abstract][Full Text] [Related]
48. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis.
Matsuno H; Yudoh K; Uzuki M; Nakazawa F; Sawai T; Yamaguchi N; Olsen BR; Kimura T
J Rheumatol; 2002 May; 29(5):890-5. PubMed ID: 12022345
[TBL] [Abstract][Full Text] [Related]
49. Molecular cloning, expression and purification of recombinant soluble mouse endostatin as an anti-angiogenic protein in Escherichia coli.
Yari K; Afzali S; Mozafari H; Mansouri K; Mostafaie A
Mol Biol Rep; 2013 Feb; 40(2):1027-33. PubMed ID: 23070914
[TBL] [Abstract][Full Text] [Related]
50. Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin.
Sasaki T; Larsson H; Kreuger J; Salmivirta M; Claesson-Welsh L; Lindahl U; Hohenester E; Timpl R
EMBO J; 1999 Nov; 18(22):6240-8. PubMed ID: 10562536
[TBL] [Abstract][Full Text] [Related]
51. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
[TBL] [Abstract][Full Text] [Related]
52. Autophagy and angiogenesis inhibition.
Ramakrishnan S; Nguyen TM; Subramanian IV; Kelekar A
Autophagy; 2007; 3(5):512-5. PubMed ID: 17643071
[TBL] [Abstract][Full Text] [Related]
53. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells].
Yang F; He YL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091
[TBL] [Abstract][Full Text] [Related]
54. Control of angiogenesis by VEGF and endostatin-encapsulated protein microcrystals and inhibition of tumor angiogenesis.
Matsumoto G; Hirohata R; Hayashi K; Sugimoto Y; Kotani E; Shimabukuro J; Hirano T; Nakajima Y; Kawamata S; Mori H
Biomaterials; 2014 Jan; 35(4):1326-33. PubMed ID: 24210874
[TBL] [Abstract][Full Text] [Related]
55. Study on glyco-modification of endostatin-derived synthetic peptide endostatin2 (ES2) by soluble chitooligosaccharide.
Yu Y; Sun F; Zhang C; Wang Z; Liu J; Tan H
Carbohydr Polym; 2016 Dec; 154():204-13. PubMed ID: 27577911
[TBL] [Abstract][Full Text] [Related]
56. Recombinant human endostatin as a potential anti-angiogenic agent: therapeutic perspective and current status.
Anakha J; Dobariya P; Sharma SS; Pande AH
Med Oncol; 2023 Dec; 41(1):24. PubMed ID: 38123873
[TBL] [Abstract][Full Text] [Related]
57. Soluble multimer of recombinant endostatin expressed in E. coli has anti-angiogenesis activity.
Wei DM; Gao Y; Cao XR; Zhu NC; Liang JF; Xie WP; Zhen MY; Zhu MS
Biochem Biophys Res Commun; 2006 Jul; 345(4):1398-404. PubMed ID: 16723120
[TBL] [Abstract][Full Text] [Related]
58. Exploring the molecular role of endostatin in diabetic neuropathy.
Mukherjee T; Behl T; Sehgal A; Bhatia S; Singh H; Bungau S
Mol Biol Rep; 2021 Feb; 48(2):1819-1836. PubMed ID: 33559819
[TBL] [Abstract][Full Text] [Related]
59. Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay.
Kruger EA; Duray PH; Tsokos MG; Venzon DJ; Libutti SK; Dixon SC; Rudek MA; Pluda J; Allegra C; Figg WD
Biochem Biophys Res Commun; 2000 Feb; 268(1):183-91. PubMed ID: 10652234
[TBL] [Abstract][Full Text] [Related]
60. Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system.
Reijerkerk A; Mosnier LO; Kranenburg O; Bouma BN; Carmeliet P; Drixler T; Meijers JC; Voest EE; Gebbink MF
Mol Cancer Res; 2003 Jun; 1(8):561-8. PubMed ID: 12805403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
